171 related articles for article (PubMed ID: 29050953)
21. Feasibility of MRI-only treatment planning for proton therapy in brain and prostate cancers: Dose calculation accuracy in substitute CT images.
Koivula L; Wee L; Korhonen J
Med Phys; 2016 Aug; 43(8):4634. PubMed ID: 27487880
[TBL] [Abstract][Full Text] [Related]
22. Investigating CT to CBCT image registration for head and neck proton therapy as a tool for daily dose recalculation.
Landry G; Nijhuis R; Dedes G; Handrack J; Thieke C; Janssens G; Orban de Xivry J; Reiner M; Kamp F; Wilkens JJ; Paganelli C; Riboldi M; Baroni G; Ganswindt U; Belka C; Parodi K
Med Phys; 2015 Mar; 42(3):1354-66. PubMed ID: 25735290
[TBL] [Abstract][Full Text] [Related]
23. Prediction of proton stopping power ratios using dual-energy CT basis material decomposition.
Pettersson E; Thilander-Klang A; Bäck A
Med Phys; 2024 Feb; 51(2):881-897. PubMed ID: 38194501
[TBL] [Abstract][Full Text] [Related]
24. Reduction of clinical safety margins in proton therapy enabled by the clinical implementation of dual-energy CT for direct stopping-power prediction.
Peters N; Wohlfahrt P; Hofmann C; Möhler C; Menkel S; Tschiche M; Krause M; Troost EGC; Enghardt W; Richter C
Radiother Oncol; 2022 Jan; 166():71-78. PubMed ID: 34774653
[TBL] [Abstract][Full Text] [Related]
25. Dual-layer spectral CT for proton, helium, and carbon ion beam therapy planning of brain tumors.
Longarino FK; Tessonnier T; Mein S; Harrabi SB; Debus J; Stiller W; Mairani A
J Appl Clin Med Phys; 2022 Jan; 23(1):e13465. PubMed ID: 34724327
[TBL] [Abstract][Full Text] [Related]
26. Influence of intravenous contrast agent on dose calculation in proton therapy using dual energy CT.
Lalonde A; Xie Y; Burgdorf B; O'Reilly S; Ingram WS; Yin L; Zou W; Dong L; Bouchard H; Teo BK
Phys Med Biol; 2019 Jun; 64(12):125024. PubMed ID: 31044743
[TBL] [Abstract][Full Text] [Related]
27. Tissue decomposition from dual energy CT data for MC based dose calculation in particle therapy.
Hünemohr N; Paganetti H; Greilich S; Jäkel O; Seco J
Med Phys; 2014 Jun; 41(6):061714. PubMed ID: 24877809
[TBL] [Abstract][Full Text] [Related]
28. Inter-centre variability of CT-based stopping-power prediction in particle therapy: Survey-based evaluation.
Taasti VT; Bäumer C; Dahlgren CV; Deisher AJ; Ellerbrock M; Free J; Gora J; Kozera A; Lomax AJ; De Marzi L; Molinelli S; Kevin Teo BK; Wohlfahrt P; Petersen JBB; Muren LP; Hansen DC; Richter C
Phys Imaging Radiat Oncol; 2018 Apr; 6():25-30. PubMed ID: 33458385
[TBL] [Abstract][Full Text] [Related]
29. Regularised patient-specific stopping power calibration for proton therapy planning based on proton radiographic images.
Krah N; Patera V; Rit S; Schiavi A; Rinaldi I
Phys Med Biol; 2019 Mar; 64(6):065008. PubMed ID: 30708365
[TBL] [Abstract][Full Text] [Related]
30. Water equivalent thickness of immobilization devices in proton therapy planning - Modelling at treatment planning and validation by measurements with a multi-layer ionization chamber.
Fellin F; Righetto R; Fava G; Trevisan D; Amelio D; Farace P
Phys Med; 2017 Mar; 35():31-38. PubMed ID: 28237409
[TBL] [Abstract][Full Text] [Related]
31. Dual- and multi-energy CT for particle stopping-power estimation: current state, challenges and potential.
Yang M; Wohlfahrt P; Shen C; Bouchard H
Phys Med Biol; 2023 Feb; 68(4):. PubMed ID: 36595276
[TBL] [Abstract][Full Text] [Related]
32. Clinical benefit of range uncertainty reduction in proton treatment planning based on dual-energy CT for neuro-oncological patients.
Taasti VT; Decabooter E; Eekers D; Compter I; Rinaldi I; Bogowicz M; van der Maas T; Kneepkens E; Schiffelers J; Stultiens C; Hendrix N; Pijls M; Emmah R; Fonseca GP; Unipan M; van Elmpt W
Br J Radiol; 2023 Sep; 96(1149):20230110. PubMed ID: 37493227
[TBL] [Abstract][Full Text] [Related]
33. Experimental validation of two dual-energy CT methods for proton therapy using heterogeneous tissue samples.
Bär E; Lalonde A; Zhang R; Jee KW; Yang K; Sharp G; Liu B; Royle G; Bouchard H; Lu HM
Med Phys; 2018 Jan; 45(1):48-59. PubMed ID: 29134674
[TBL] [Abstract][Full Text] [Related]
34. A robust empirical parametrization of proton stopping power using dual energy CT.
Taasti VT; Petersen JB; Muren LP; Thygesen J; Hansen DC
Med Phys; 2016 Oct; 43(10):5547. PubMed ID: 27782721
[TBL] [Abstract][Full Text] [Related]
35. Comprehensive analysis of proton range uncertainties related to stopping-power-ratio estimation using dual-energy CT imaging.
Li B; Lee HC; Duan X; Shen C; Zhou L; Jia X; Yang M
Phys Med Biol; 2017 Aug; 62(17):7056-7074. PubMed ID: 28678019
[TBL] [Abstract][Full Text] [Related]
36. An evaluation of the use of DirectSPR images for proton planning in the RayStation treatment planning software.
Sarkar V; Paxton A; Su F; Price R; Nelson G; Szegedi M; James SS; Salter BJ
J Appl Clin Med Phys; 2023 May; 24(5):e13900. PubMed ID: 36625438
[TBL] [Abstract][Full Text] [Related]
37. Feasibility of automated proton therapy plan adaptation for head and neck tumors using cone beam CT images.
Kurz C; Nijhuis R; Reiner M; Ganswindt U; Thieke C; Belka C; Parodi K; Landry G
Radiat Oncol; 2016 Apr; 11():64. PubMed ID: 27129305
[TBL] [Abstract][Full Text] [Related]
38. Optimization of dual-energy CT acquisitions for proton therapy using projection-based decomposition.
Vilches-Freixas G; Létang JM; Ducros N; Rit S
Med Phys; 2017 Sep; 44(9):4548-4558. PubMed ID: 28675582
[TBL] [Abstract][Full Text] [Related]
39. Ex vivo validation of a stoichiometric dual energy CT proton stopping power ratio calibration.
Xie Y; Ainsley C; Yin L; Zou W; McDonough J; Solberg TD; Lin A; Teo BK
Phys Med Biol; 2018 Mar; 63(5):055016. PubMed ID: 29513647
[TBL] [Abstract][Full Text] [Related]
40. Optimal energy selection for proton stopping-power-ratio estimation using dual-energy CT-based monoenergetic imaging.
Je E; Lee HH; Duan X; Li B; Jia X; Yang M
Phys Med Biol; 2019 Oct; 64(19):195015. PubMed ID: 31437824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
